THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 108 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $463,586 | +4.9% | 53,718 | +25.8% | 0.00% | – |
| Q2 2023 | $442,059 | +52.5% | 42,711 | +59.8% | 0.00% | – |
| Q1 2023 | $289,955 | +198.6% | 26,724 | +208.7% | 0.00% | – |
| Q4 2022 | $97,120 | +9612.0% | 8,656 | +8556.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 100 | -65.9% | 0.00% | – |
| Q2 2022 | $2,000 | -94.1% | 293 | -91.7% | 0.00% | – |
| Q1 2022 | $34,000 | +25.9% | 3,549 | +45.0% | 0.00% | – |
| Q4 2021 | $27,000 | +350.0% | 2,448 | +220.0% | 0.00% | – |
| Q3 2021 | $6,000 | +500.0% | 765 | +665.0% | 0.00% | – |
| Q2 2021 | $1,000 | -100.0% | 100 | -100.0% | 0.00% | -100.0% |
| Q1 2021 | $4,471,000 | +49.6% | 219,038 | +30.2% | 0.00% | 0.0% |
| Q4 2020 | $2,989,000 | +144.4% | 168,199 | +103.2% | 0.00% | – |
| Q3 2020 | $1,223,000 | +2207.5% | 82,774 | +3178.2% | 0.00% | – |
| Q2 2020 | $53,000 | -49.0% | 2,525 | -43.6% | 0.00% | – |
| Q1 2020 | $104,000 | +60.0% | 4,478 | +77.3% | 0.00% | – |
| Q4 2019 | $65,000 | -98.3% | 2,525 | -98.7% | 0.00% | -100.0% |
| Q3 2019 | $3,898,000 | +3069.1% | 200,102 | +2547.9% | 0.00% | – |
| Q2 2019 | $123,000 | +9.8% | 7,557 | +52.8% | 0.00% | – |
| Q1 2019 | $112,000 | -85.1% | 4,946 | -83.2% | 0.00% | – |
| Q4 2018 | $754,000 | +275.1% | 29,492 | +378.1% | 0.00% | – |
| Q3 2018 | $201,000 | +187.1% | 6,168 | +99.9% | 0.00% | – |
| Q2 2018 | $70,000 | -35.8% | 3,085 | -31.6% | 0.00% | – |
| Q1 2018 | $109,000 | +62.7% | 4,511 | +88.4% | 0.00% | – |
| Q4 2017 | $67,000 | -72.9% | 2,394 | -66.8% | 0.00% | – |
| Q3 2017 | $247,000 | +157.3% | 7,219 | +197.7% | 0.00% | – |
| Q2 2017 | $96,000 | +1271.4% | 2,425 | +1112.5% | 0.00% | – |
| Q1 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | -95.0% | 200 | -93.9% | 0.00% | – |
| Q3 2016 | $119,000 | +466.7% | 3,283 | +240.6% | 0.00% | – |
| Q2 2016 | $21,000 | -19.2% | 964 | -31.9% | 0.00% | – |
| Q1 2016 | $26,000 | -71.4% | 1,415 | -74.6% | 0.00% | – |
| Q4 2015 | $91,000 | +1416.7% | 5,561 | +1012.2% | 0.00% | – |
| Q3 2015 | $6,000 | -50.0% | 500 | -42.8% | 0.00% | – |
| Q2 2015 | $12,000 | -20.0% | 874 | 0.0% | 0.00% | – |
| Q1 2015 | $15,000 | -64.3% | 874 | -68.8% | 0.00% | – |
| Q4 2014 | $42,000 | – | 2,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |